Examination of Low ERBB2 Protein Expression in Breast Cancer TissueAileen I. Fernandez, David L. Rimm, Matthew Liu et al.|JAMA Oncology|2022Cited by 347
Association of Event-Free and Distant Recurrence–Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast CancerDouglas Yee, Minetta C. Liu, Brian Datnow et al.|JAMA Oncology|2020Cited by 225
Multi-institutional Assessment of Pathologist Scoring HER2 ImmunohistochemistryCharles T. Robbins, David L. Rimm, Aileen I. Fernandez et al.|Modern Pathology|2023Cited by 98
Multi-institutional Assessment of Pathologist scoring HER2 ImmunohistochemistryCharles T. Robbins, David L. Rimm, Aileen I. Fernandez et al.|Research Square|2022Cited by 7
Abstract P1-02-02: Examination of low Her2 expression in breast cancerAileen I. Fernandez, David L. Rimm, Matthew Liu et al.|Cancer Research|2022Cited by 1